“Home mechanical ventilation: A Canadian Thoracic Society clinical practice guideline”
by McKim DA, Road J, Avendano M, Abdool S, Cote F, Duguid N, Fraser J, Maltais F, Morrison DL, O'Connell C, Petrof BJ, Rimmer K, Skomro R was published in the July 2011 [18(4):197-215] Canadian Respiratory Journal. The Canadian Thoracic Society HMV Guideline Committee has reviewed the available English literature on topics related to HMV in adults and completed a detailed guideline that will help standardize and improve the assessment and management of individuals requiring noninvasive or invasive HMV.
To access the article please click here:
Amyotrophic Lateral Sclerosis (ALS): The Diagnosis and Treatment of this Debilitating Disease
This article by Dr Andrew Eisen, Vancouver, BC, was originally published in Geriatrics and Aging
Originally published in: Volume 3, Number 9, November 2000
In 1869, french neurologist Jean-Martin Charcot first described a rapidly progressive, fatal neuromuscular disease. This disease, amyotrophic lateral sclerosis, or Lou-Gehrig's disease, is a neurodegenerative disorder that affects the patient's motor neurons; typically the patient is paralyzed or deceased within 2 to 5 years of the initial diagnosis. Currently, approximately 3000 Canadians suffer from this tragic disease.
ALS/MND: The Dangers of Unproven "Therapies"
All of those involved in ALS/MND, be they health professionals, care-givers and, most of all, patients with ALS/MND are only too aware of the grave significance and implications of the disease. This results in a variable degree of desperation which makes all three vulnerable to “try anything” for “what is there to loose”? There are several categories of drug therapy.